Cell monitors size and DNA integrity occurs at G1/S checkpoint.
The G1/S transition represents the restriction point where cells assess growth status, nutrient availability, and genomic integrity before committing to DNA replication, preventing propagation of damaged genomes.
Option Analysis
Cell monitors DNA synthesis and damage
DNA synthesis occurs during S phase, post-G1/S checkpoint. G2/M checkpoint monitors replication completion/damage. G1/S assesses pre-replicative DNA integrity. Incorrect.
Cell monitors spindle formation
Spindle assembly checkpoint operates at metaphase-anaphase M phase transition, ensuring microtubule-kinetochore attachments. G1/S unrelated. Incorrect.
Attachment to kinetochores
Kinetochore-microtubule attachment verification occurs during prometaphase M phase via SAC (Mad2/BubR1). G1 cells lack condensed chromosomes/kinetochores. Incorrect.
Cell monitors size and DNA integrity
Restriction point: Rb hyperphosphorylation (CyclinD-CDK4/6 → CyclinE-CDK2) releases E2F for S-phase gene transcription. ATM/ATR-p53-p21 pathway halts progression if DNA damage detected pre-replication. Cell growth to critical mass also required. Correct.
Event that occurs at G1/S checkpoint—the primary restriction point—determines eukaryotic cell fate: proliferation, quiescence (G0), or apoptosis based on extracellular mitogens and intracellular homeostasis.
Checkpoint Sensing Mechanisms
Size control: Ribosome biogenesis, protein synthesis during G1 increase cell mass. CyclinE-CDK2 threshold requires ~1.8-2.2 pg protein/cell in mammalian fibroblasts. Myc-driven biomass accumulation essential.
DNA integrity: ATM/ATR kinases detect double/single-strand breaks. p53 stabilization → p21(CDKN1A) inhibits CDK2, maintaining Rb-E2F repression. Unrepaired lesions trigger permanent G1 arrest or senescence.
Molecular Circuitry
Growth factors → Ras → CyclinD ↑ → CDK4/6 phosphorylates Rb → Partial E2F release
↓
CyclinE ↑ → CDK2 fully phosphorylates Rb → E2F activation → S-phase genes (PCNA, MCM, DNA Pol α)
↓ [if DNA damage detected]
ATM/ATR → Chk1/Chk2 → p53 → p21 → CDK2 inhibition → G1 arrest
Checkpoint Failure Consequences
p53/Rb pathway mutations (90% human cancers) abrogate G1/S control, forcing reliance on G2/M checkpoint. HPV E7/E1A, Adenovirus E1B inactivate Rb/p53 respectively, enabling viral replication in cycling cells.